Results 31 to 40 of about 681 (134)

Effectiveness and Persistence in SB4‐ and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway

open access: yesArthritis Care &Research, Volume 75, Issue 9, Page 1986-1995, September 2023., 2023
Objective Biosimilars represent cost‐effective alternatives to reference biologic disease‐modifying antirheumatic drugs. Our objective was to compare drug effectiveness and drug persistence in the treatment of rheumatoid arthritis (RA), assessing the etanercept biosimilar SB4 in efficacy and safety compared with reference etanercept in a Phase III ...
Glenn Haugeberg   +5 more
wiley   +1 more source

Cross-cultural adaptation and validation of the Thai version of the functional index for hand osteoarthritis (FIHOA)

open access: yesBMC Musculoskeletal Disorders, 2022
Background The Functional Index for Hand Osteoarthritis (FIHOA) is a simple tool to assess functional impairment for hand OA patients. The purpose of this study was to translate the FIHOA into the Thai language, and validate it in Thai hand OA patients ...
Sitthiphong Suwannaphisit   +4 more
doaj   +1 more source

Strategies to enhance physical activity in people with Rheumatoid Arthritis: A Delphi survey

open access: yesMusculoskeletal Care, Volume 21, Issue 3, Page 723-732, September 2023., 2023
Abstract Introduction Managing symptoms, resisting functional decline and maintaining health and independence are key motivators for people with Rheumatoid Arthritis (RA) who successfully engage with physical activity (PA). To inform PA support for people with RA the aim was to determine whether the broader RA population share similar beliefs and ...
Rachel Thomas   +3 more
wiley   +1 more source

Scale Banking for Patient‐Reported Outcome Measures That Measure Functioning in Rheumatoid Arthritis: A Daily Activities Metric

open access: yesArthritis Care &Research, Volume 74, Issue 4, Page 579-587, April 2022., 2022
Objective Functioning is an important outcome for the management of rheumatoid arthritis (RA). Heterogeneity of respective patient‐reported outcome measures (PROMs) challenges direct comparisons between their results. This study aimed to standardize reporting of such PROMs measuring functioning in RA to facilitate comparability.
Birgit Prodinger   +4 more
wiley   +1 more source

AB0225 Characteristics of mhaq for upper and lower extremity function, and relationship with age and disease activity in rheumatoid arthritis patient [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2017
Background Activity in daily living (ADL) is one of main target to maintain patient9s quality of life in rheumatoid arthritis (RA) treatment. Modified Health Assessment Questionnaire (mHAQ) is a most popular index for ADL in routine practice. mHAQ is separated according to function of extremity; namely the first four categories are reflections of ...
I Yoshii, T Chijiwa
openaire   +1 more source

Oral and Intestinal Bacterial Substances Associated with Disease Activities in Patients with Rheumatoid Arthritis: A Cross‐Sectional Clinical Study

open access: yesJournal of Immunology Research, Volume 2022, Issue 1, 2022., 2022
Intestinal bacterial compositions of rheumatoid arthritis (RA) patients have been reported to be different from those of healthy people. Dysbiosis, imbalance of the microbiota, is widely known to cause gut barrier damage, resulting in an influx of bacteria and their substances into host bloodstreams in animal studies.
Kaori Kitamura   +12 more
wiley   +1 more source

Effect of interleukin-17A inhibitor in Japanese patients with psoriatic arthritis compared with tumor necrosis factor-alpha inhibitor

open access: yesJournal of Orthopaedic Surgery, 2021
Objectives: The patient of severe psoriatic arthritis (PsA) is mainly treated with oral methotrexate, ciclosporin, and anti-tumor necrosis factor-alpha inhibitors (TNFi). Recently, anti-interleukin-17A inhibitors (IL-17Ai) have been used in the treatment
Takuya Izumiyama   +8 more
doaj   +1 more source

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis

open access: yesACR Open Rheumatology, Volume 3, Issue 12, Page 889-896, December 2021., 2021
Objective In this study, we aimed to determine the lifetime prevalence of substance use disorder (SUD) in a Canadian rheumatoid arthritis (RA) cohort and factors associated with SUD in RA. Methods Participants with RA (N = 154) were recruited via rheumatology clinics as part of a larger cohort study of psychiatric comorbidity in immune‐mediated ...
Kaarina Kowalec   +25 more
wiley   +1 more source

Definition of activity cut-off point in patients with Behçet’s disease using the Arabic version of the Behcet’s Syndrome Activity Scale. [PDF]

open access: yesZagazig University Medical Journal, 2023
Background: Behçet’s disease (BD) activity assessment is a major concern since a treat-to-target approach may lead to a better prognosis. The first patient-reported assessment instrument, the Behçet's Syndrome Activity Score (BSAS), is useful for routine
dalia moatafa   +3 more
doaj   +1 more source

Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, Volume 73, Issue 7, Page 947-954, July 2021., 2021
Objective As young people enter adulthood, the interchangeable use of child and adult outcome measures may inaccurately capture changes over time. This study aimed to use item response theory (IRT) to model a continuous score for functional ability that can be used no matter which questionnaire is completed.
Stephanie J. W. Shoop‐Worrall   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy